IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma

(MedPage Today) -- Use of intravenous immunoglobulin (IVIg) may substantially reduce the risk for severe infections in multiple myeloma patients treated with an anti-B-cell maturation antigen (BCMA) bispecific antibody, a small retrospective study...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news